Carregant...

Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells

The kinase deficient erbB3 receptor frequently co-expresses and interacts with erbB2 in human breast cancer to activate the oncogenic signaling pathways, and thus promote breast cancer cell survival/proliferation. In the current study, we discovered that the expression of endogenous mouse erbB3 was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Exp Pathol
Autors principals: Lyu, Hui, Huang, Jingcao, Edgerton, Susan M, Thor, Ann D, He, Zhimin, Liu, Bolin
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525826/
https://ncbi.nlm.nih.gov/pubmed/26261492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!